Vietnamese-founded Drylab bags US$3M to put autonomous AI scientists inside pharma labs
The cost of sequencing a human genome fell from about US$95 million in 2001 to about US$500 by 2022, according to the US National Human Genome Research Institute. Biology became a data business almost overnight. The ability to make sense of that data did not keep pace. Most laboratories now generate more sequencing, imaging and […] The post Vietnamese-founded Drylab bags US$3M to put autonomous…
Drylab, a Vietnam-founded AI startup, has secured US$3 million in seed funding to develop autonomous AI scientists for pharmaceutical and biotech research and development (R&D). The Singapore-based company, founded by a Vietnamese team, aims to streamline the data-intensive processes that plague life sciences labs, where sequencing and imaging data often outpace staff's ability to analyze it.
Drylab's unique selling point is its agentic AI agents, which can own the entire computational research workflow, interpret scientific objectives, plan analyses, select tools and databases, provision computing resources, and troubleshoot failures without human intervention. The company's innovation lies in a proprietary verification model that ensures the agents' analytical decisions are methodologically sound.
Drylab's platform allows customers to deploy the AI agents on their private infrastructure or local workstations, ensuring that the learning remains within the customer's environment. This approach is crucial for pharmaceutical companies, whose proprietary data is their most valuable asset. The funding will be used for enterprise sales hires, expanding engineering and biology teams, and securing the necessary certifications to gain the trust of larger research organizations.
Written by urgent.news from e27's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
